Neurobiological Technologies Price History
NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Neurobiological Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neurobiological Technologies stands at 0.0001, as last reported on the 15th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Neurobiological Technologies, which you can use to evaluate the volatility of the firm.
Neurobiological Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neurobiological |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NTII |
Based on monthly moving average Neurobiological Technologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurobiological Technologies by adding Neurobiological Technologies to a well-diversified portfolio.
Neurobiological Technologies Stock Price History Chart
There are several ways to analyze Neurobiological Stock price data. The simplest method is using a basic Neurobiological candlestick price chart, which shows Neurobiological Technologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Neurobiological Stock Price History Data
The price series of Neurobiological Technologies for the period between Mon, Sep 16, 2024 and Sun, Dec 15, 2024 has a statistical range of 0.0 with a coefficient of variation of 0.0. The daily prices for the period are spread out with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company underwent 1:7 stock split on 17th of September 2007. Neurobiological Technologies issued dividends to stockholders on 2012-12-27.Open | High | Low | Close | Volume | ||
12/15/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | ||
07/10/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
07/07/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
07/06/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
07/05/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
07/03/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/30/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/29/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/28/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/27/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/26/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/23/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/22/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/21/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/20/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/16/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/15/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/14/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/13/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/12/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/09/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/08/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/07/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/06/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/05/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/02/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/01/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/31/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/30/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/26/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/25/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/24/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/23/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/22/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/19/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/18/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/17/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/16/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/15/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/12/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/11/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/10/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/09/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/08/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/05/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/04/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/03/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/02/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/01/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/28/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/27/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/26/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/25/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/24/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/21/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/20/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/19/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/18/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/17/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/14/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
04/13/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
About Neurobiological Technologies Stock history
Neurobiological Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurobiological is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurobiological Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurobiological Technologies stock prices may prove useful in developing a viable investing in Neurobiological Technologies
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. The company was founded in 1987 and is based in Emeryville, California. Neurobiological Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Neurobiological Technologies Stock Technical Analysis
Neurobiological Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stocks Directory Find actively traded stocks across global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |